108 related articles for article (PubMed ID: 8791773)
1. Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase.
Kupfer D; Dehal SS
Methods Enzymol; 1996; 272():152-63. PubMed ID: 8791773
[No Abstract] [Full Text] [Related]
2. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
Kupfer D; Mani C; Lee CA; Rifkind AB
Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic analysis of tamoxifen, toremifene and their major human metabolites.
Berthou F; Dréano Y
J Chromatogr; 1993 Jun; 616(1):117-27. PubMed ID: 8376482
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.
Hukkanen J; Mäntylä M; Kangas L; Wirta P; Hakkola J; Paakki P; Evisalmi S; Pelkonen O; Raunio H
Pharmacol Toxicol; 1998 Feb; 82(2):93-7. PubMed ID: 9498238
[TBL] [Abstract][Full Text] [Related]
6. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
[TBL] [Abstract][Full Text] [Related]
7. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Dehal SS; Brodie AM; Kupfer D
Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
Mani C; Hodgson E; Kupfer D
Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazole.
Kedderis GL; Rickert DE
Biochem Biophys Res Commun; 1983 Jun; 113(2):433-8. PubMed ID: 6870866
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
[TBL] [Abstract][Full Text] [Related]
11. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
12. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
Crewe HK; Ellis SW; Lennard MS; Tucker GT
Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
[TBL] [Abstract][Full Text] [Related]
13. Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.
Jacolot F; Simon I; Dreano Y; Beaune P; Riche C; Berthou F
Biochem Pharmacol; 1991 Jun; 41(12):1911-9. PubMed ID: 2039544
[TBL] [Abstract][Full Text] [Related]
14. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.
Moroni P; Buronfosse T; Longin-Sauvageon C; Delatour P; Benoit E
Drug Metab Dispos; 1995 Feb; 23(2):160-5. PubMed ID: 7736906
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
Mani C; Kupfer D
Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
[TBL] [Abstract][Full Text] [Related]
16. Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.
Williams DE; Katchamar S; Larsen-Su SA; Stresser DM; Dehal SS; Kupfer D
Adv Exp Med Biol; 2001; 500():635-8. PubMed ID: 11765009
[No Abstract] [Full Text] [Related]
17. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
Dehal SS; Kupfer D
Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes.
Caputo O; Grosa G; Ceruti M; Rocco F; Biglino G
Drug Metab Dispos; 1990; 18(5):771-8. PubMed ID: 1981735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
